Skip to main content

and
  1. No Access

    Article

    Solitary Hepatic Infantile Myofibromatosis in a Female Adolescent

    P. Hastier, F. X. Caroli-Bosc, A. G. Harris in Digestive Diseases and Sciences (1998)

  2. No Access

    Article

    Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritis

    Pyoderma gangrenosum is a dermatological disease of unknown origin. We report the case of a 47-year-old woman with cutaneous lesions of pyoderma gangrenosum associated with hepaticopancreatic involvement. We f...

    P. Hastier, F. X. Caroli-Bosc, H. R. Bartel in Digestive Diseases and Sciences (1996)

  3. No Access

    Article

    Consensus statement: Octreotide dose titration in secretory diarrhea

    Octreotide is an effective therapeutic option in controlling secretory diarrhea of varied etiology. However, marked patient-to-patient differences in the antidiarrheal effects necessitate titration of octreoti...

    A. G. Harris, Dr. T. M. O'Dorisio, E. A. Woltering in Digestive Diseases and Sciences (1995)

  4. No Access

    Article

    Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly

    Treatment with the somatostatin analog octreotide is associated with increased gallstone formation. The mechanism of formation of these stones is unclear. The purpose of this study was to examine the effect of...

    Dr. S. Erlinger, P. Chanson, M. Dumont, P. Ponsot in Digestive Diseases and Sciences (1994)

  5. No Access

    Chapter and Conference Paper

    Receptors and Their Modulation

    The potential for hormonal intervention in cancer was identified as early as 1895, even before the concept of hormones was established. Indeed, we know that the first hormone was discovered only in 1902 (secre...

    F. X. Caroli-Bosc, P. Hastier, A. G. Harris, P. Gaudray in Facing the Pancreatic Dilemma (1994)